Mycobacterium Citations List: August, 2016

Literature Citations

1. Dual Targeting of Intracellular Pathogenic Bacteria with a Cleavable Conjugate of Kanamycin and an Antibacterial Cell-penetrating Peptide. Brezden, A., M.F. Mohamed, M. Nepal, J.S. Harwood, J. Kuriakose, M.N. Seleem, and J. Chmielewski. Journal of the American Chemical Society, 2016. 138(34): p. 10945-10949. PMID[27494027].
[PubMed]. TB_08_2016.

2. Antimycobacterial Activity of Medicinal Plants Used by the Mayo People of Sonora, Mexico. Coronado-Aceves, E.W., J.J. Sanchez-Escalante, J. Lopez-Cervantes, R.E. Robles-Zepeda, C. Velazquez, D.I. Sanchez-Machado, and A. Garibay-Escobar. Journal of Ethnopharmacology, 2016. 190: p. 106-115. PMID[27262564].
[PubMed]. TB_08_2016.

3. A Small-molecule Screening Platform for the Discovery of Inhibitors of Undecaprenyl diphosphate Synthase. Czarny, T.L. and E.D. Brown. ACS Infectious Diseases, 2016. 2(7): p. 489-499. ISI[000379638600007].
[WOS]. TB_08_2016.

4. Preparation, Biological Evaluation and Molecular Docking Study of Imidazolyl dihydropyrimidines as Potential Mycobacterium tuberculosis Dihydrofolate Reductase Inhibitors. Desai, N.C., A.R. Trivedi, and V.M. Khedkar. Bioorganic & Medicinal Chemistry Letters, 2016. 26(16): p. 4030-4035. PMID[27397497].
[PubMed]. TB_08_2016.

5. Synthesis and Antitubercular Activity of New 1,3,4-Oxadiazoles Bearing Pyridyl and Thiazolyl Scaffolds. Dhumal, S.T., A.R. Deshmukh, M.R. Bhosle, V.M. Khedkar, L.U. Nawale, D. Sarkar, and R.A. Mane. Bioorganic & Medicinal Chemistry Letters, 2016. 26(15): p. 3646-3651. PMID[27301367].
[PubMed]. TB_08_2016.

6. A New Piperidinol Derivative Targeting Mycolic acid Transport in Mycobacterium abscessus. Dupont, C., A. Viljoen, F. Dubar, M. Blaise, A. Bernut, A. Pawlik, C. Bouchier, R. Brosch, Y. Guerardel, J. Lelievre, L. Ballell, J.L. Herrmann, C. Biot, and L. Kremer. Molecular Microbiology, 2016. 101(3): p. 515-529. PMID[27121350].
[PubMed]. TB_08_2016.

7. Activity of Phosphino Palladium(II) and Platinum(II) Complexes against HIV-1 and Mycobacterium tuberculosis. Gama, N.H., A.Y. Elkhadir, B.G. Gordhan, B.D. Kana, J. Darkwa, and D. Meyer. Biometals: An International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine, 2016. 29(4): p. 637-650. PMID[27246555].
[PubMed]. TB_08_2016.

8. Synthesis and Antituberculosis Activity of the First Macrocyclic Glycoterpenoids Comprising Glucosamine and Diterpenoid Isosteviol. Garifullin, B.F., I.Y. Strobykina, R.R. Sharipova, M.A. Kravchenko, O.V. Andreeva, O.B. Bazanova, and V.E. Kataev. Carbohydrate Research, 2016. 431: p. 15-24. PMID[27267064].
[PubMed]. TB_08_2016.

9. N-Alkoxyphenylhydroxynaphthalenecarboxamides and Their Antimycobacterial Activity. Gonec, T., S. Pospisilova, T. Kauerova, J. Kos, J. Dohanosova, M. Oravec, P. Kollar, A. Coffey, T. Liptaj, A. Cizek, and J. Jampilek. Molecules, 2016. 21(8): E1068. PMID[27537867].
[PubMed]. TB_08_2016.

10. Bioassay-guided Isolation and Structural Modification of the anti-TB Resorcinols from Ardisia gigantifolia. Guan, Y.F., X. Song, M.H. Qiu, S.H. Luo, B.J. Wang, N. Van Hung, N.M. Cuong, D.D. Soejarto, H.H. Fong, S.G. Franzblau, S.H. Li, Z.D. He, and H.J. Zhang. Chemical Biology & Drug Design, 2016. 88(2): p. 293-301. PMID[26992112].
[PubMed]. TB_08_2016.

11. Propargyl-linked Antifolates Are Potent Inhibitors of Drug-sensitive and Drug-resistant Mycobacterium tuberculosis. Hajian, B., E. Scocchera, S. Keshipeddy, G.D. N, C. Shoen, J. Krucinska, S. Reeve, M. Cynamon, A.C. Anderson, and D.L. Wright. Plos One, 2016. 11(8): p. e0161740. PMID[27580226].
[PubMed]. TB_08_2016.

12. Rational Design and Synthesis of Novel Diphenyl ether Derivatives as Antitubercular Agents. Kar, S.S., V. Bhat, P.P.N. Rao, V.P. Shenoy, I. Bairy, and G.G. Shenoy. Drug Design Development and Therapy, 2016. 10: p. 2299-2310. PMID[27486307]. PMCID[PMC4958353].
[PubMed].

13. An Evolved Oxazolidinone with Selective Potency against Mycobacterium tuberculosis and Gram Positive Bacteria. Kaushik, A., A.M. Heuer, D.T. Bell, J.C. Culhane, D.C. Ebner, N. Parrish, J.T. Ippoliti, and G. Lamichhane. Bioorganic & Medicinal Chemistry Letters, 2016. 26(15): p. 3572-3576. PMID[27329794]. PMCID[PMC4955536].
[PubMed]. TB_08_2016.

14. Total Synthesis and Stereochemical Revision of the Anti-tuberculosis Peptaibol Trichoderin A. Kavianinia, I., L. Kunalingam, P.W. Harris, G.M. Cook, and M.A. Brimble. Organic Letters, 2016. 18(15): p. 3878-3881. PMID[27467118].
[PubMed]. TB_08_2016.

15. Unnatural Amino acid Analogues of Membrane-active Helical Peptides with Anti-mycobacterial Activity and Improved Stability. Khara, J.S., M. Priestman, I. Uhia, M.S. Hamilton, N. Krishnan, Y. Wang, Y.Y. Yang, P.R. Langford, S.M. Newton, B.D. Robertson, and P.L. Ee. The Journal of Antimicrobial Chemotherapy, 2016. 71(8): p. 2181-2191. PMID[27118774].
[PubMed]. TB_08_2016.

16. Synthesis and Antibacterial Evaluation of Macrocyclic Diarylheptanoid Derivatives. Lin, H., D.F. Bruhn, M.M. Maddox, A.P. Singh, R.E. Lee, and D. Sun. Bioorganic Medicinal Chemistry Letters, 2016. 26(16): p. 4070-4076. PMID[27406794]. PMCID[PMC4969171].
[PubMed]. TB_08_2016.

17. Synthesis and Evaluation of Bicyclo[3.1.0]hexane-based UDP-Galf Analogues as Inhibitors of the Mycobacterial Galactofuranosyltransferase GlfT2. Lowary, T.L. and J. Li. Molecules, 2016. 21(8): E1053. PMID[27529206].
[PubMed]. TB_08_2016.

18. Synthesis and Antitubercular Activity of New Benzo[b]thiophenes. Mahajan, P.S., M.D. Nikam, L.U. Nawale, V.M. Khedkar, D. Sarkar, and C.H. Gill. ACS Medicinal Chemistry Letters, 2016. 7(8): p. 751-756. PMID[27563398]. PMCID[PMC4983740].
[PubMed]. TB_08_2016.

19. Synthesis and Molecular Docking Studies of a New Series of Bipyrazol-yl-thiazol-ylidene-hydrazinecarbothioamide Derivatives as Potential Antitubercular Agents. Mogle, P.P., R.J. Meshram, S.V. Hese, R.D. Kamble, S.S. Kamble, R.N. Gacche, and B.S. Dawane. MedChemComm, 2016. 7(7): p. 1405-1420. ISI[000379431300016].
[WOS]. TB_08_2016.

20. Design, Synthesis, and in Vitro Antituberculosis Activity of 2(5H)-Furanone Derivatives. Ngwane, A.H., J.L. Panayides, F. Chouteau, L. Macingwana, A. Viljoen, B. Baker, E. Madikane, C. de Kock, L. Wiesner, K. Chibale, C.J. Parkinson, E.M. Mmutlane, P. van Helden, and I. Wiid. IUBMB Life, 2016. 68(8): p. 612-620. PMID[27346745].
[PubMed]. TB_08_2016.

21. Synthesis, 3D-QSAR Analysis and Biological Evaluation of Quinoxaline 1,4-di-N-oxide Derivatives as Antituberculosis Agents. Pan, Y., P. Li, S. Xie, Y. Tao, D. Chen, M. Dai, H. Hao, L. Huang, Y. Wang, L. Wang, Z. Liu, and Z. Yuan. Bioorganic & Medicinal Chemistry Letters, 2016. 26(16): p. 4146-4153. PMID[27426298].
[PubMed]. TB_08_2016.

22. Design, Synthesis and Biological Evaluation of Novel 1,2,3-Triazolyl-hydroxy Alkyl/Carbazole Hybrid Molecules. Rad, M.N.S., S. Behrouz, M. Behrouz, A. Sami, M. Mardkhoshnood, A. Zarenezhad, and E. Zarenezhad. Molecular Diversity, 2016. 20(3): p. 705-718. PMID[27278443].
[PubMed].

23. Identification of Novel 2-Aminothiazole Conjugated Nitrofuran as Antitubercular and Antibacterial Agents. Ran, K., C. Gao, H. Deng, Q. Lei, X. You, N. Wang, Y. Shi, Z. Liu, W. Wei, C. Peng, L. Xiong, K. Xiao, and L. Yu. Bioorganic & Medicinal Chemistry Letters, 2016. 26(15): p. 3669-3674. PMID[27289321].
[PubMed]. TB_08_2016.

24. Helvolic acid, a Secondary Metabolite Produced by Neosartorya spinosa KKU-1NK1 and Its Biological Activities. Sanmanoch, W., W. Mongkolthanaruk, S. Kanokmedhakul, T. Aimi, and S. Boonlue. Chiang Mai Journal of Science, 2016. 43(3): p. 484-494. ISI[000379368900007].
[WOS]. TB_08_2016.

25. Fragment Discovery for the Design of Nitrogen Heterocycles as Mycobacterium Tuberculosis Dihydrofolate Reductase Inhibitors. Shelke, R.U., M.S. Degani, A. Raju, M.K. Ray, and M.G. Rajan. Archiv der Pharmazie, 2016. 349(8): p. 602-613. PMID[27320965].
[PubMed]. TB_08_2016.

26. Inhibition of Mycobacterium Tuberculosis Dihydrodipicolinate Synthase by alpha-Ketopimelic acid and Its Other Structural Analogues. Shrivastava, P., V. Navratna, Y. Silla, R.P. Dewangan, A. Pramanik, S. Chaudhary, G. Rayasam, A. Kumar, B. Gopal, and S. Ramachandran. Scientific Reports, 2016. 6: 30827. PMID[27501775]. PMCID[PMC4977564].
[PubMed]. TB_08_2016.

27. Click-based Synthesis and Antitubercular Evaluation of Dibenzofuran Tethered Thiazolyl-1,2,3-triazolyl acetamides. Surineni, G., P. Yogeeswari, D. Sriram, and S. Kantevari. Bioorganic & Medicinal Chemistry Letters, 2016. 26(15): p. 3684-3689. PMID[27317646].
[PubMed]. TB_08_2016.

28. Mycobacterial Antigen 85 Complex (Ag85) as a Target for Ficolins and Mannose-binding Lectin. Swierzko, A.S., M.A. Bartlomiejczyk, A. Brzostek, J. Tukasiewicz, M. Michalski, J. Dziadek, and M. Cedzynski. International Journal of Medical Microbiology, 2016. 306(4): p. 212-221. PMID[27141819].
[PubMed].

29. Synthesis and Evaluation of Antitubercular Activity of Fluorinated 5-Aryl-4-(hetero)aryl Substituted Pyrimidines. Verbitskiy, E.V., S.A. Baskakova, M.A. Kravchenko, S.N. Skornyakov, G.L. Rusinov, O.N. Chupakhin, and V.N. Charushin. Bioorganic & Medicinal Chemistry, 2016. 24(16): p. 3771-3780. PMID[27338658].
[PubMed]. TB_08_2016.

30. Wild-type and Non-wild-type Mycobacterium tuberculosis MIC Distributions for the Novel Fluoroquinolone Antofloxacin Compared with Those for Ofloxacin, Levofloxacin, and Moxifloxacin. Yu, X., G. Wang, S. Chen, G. Wei, Y. Shang, L. Dong, T. Schon, D. Moradigaravand, J. Parkhill, S.J. Peacock, C.U. Koser, and H. Huang. Antimicrobial Agents and Chemotherapy, 2016. 60(9): p. 5232-5237. PMID[27324769].
[PubMed]. TB_08_2016.

Patent Citations

31. 4-Substituted Benzoxaborole Compounds and Uses Thereof. Alemparte-Gallardo, C., M.R.K. Alley, D. Barros-Aguirre, I. Giordano, V. Hernandez, X. Li, and J.J. Plattner. Patent. 2016. 2016-IB50775 2016128948: 110pp.

[Patent]. TB_08_2016.

32. Benzoxaborole Compounds and Uses Thereof. Alley, M.R.K., D. Barros-Aguirre, I. Giordano, V. Hernandez, X. Li, and J.J. Plattner. Patent. 2016. 2016-IB50776 2016128949: 152pp.

[Patent]. TB_08_2016.

33. Benzimidazole Sulfide Derivatives for the Treatment or Prevention of Tuberculosis. Cole, S. and J.L. Rybniker. Patent. 2016. 2015-152650 3050565: 31pp.

[Patent]. TB_08_2016.

34. Bortezomib as an Inhibitor of Mycobacterial Caseinolytic Protease (CLP) for Treatment of Tuberculosis. Dick, T., W. Moreira, E.J. Rubin, R. Raju, and C.S.B. Chia. Patent. 2016. 2016-US16658 2016127003: 56pp.

[Patent]. TB_08_2016.

35. Nitroimidazole Derivatives as Anti-pulmonary Tuberculosis Agents and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of Tuberculosis. Luo, W., C.Z. Ding, and Z. Huang. Patent. 2016. 2016-CN72447 2016119706: 180pp.

[Patent]. TB_08_2016.